Inhibition of CTL-line lysis after gangliosides treatment.

doi:10.1016/1043-6618(92)90659-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Inhibition of CTL-line lysis after gangliosides treatment.

Pharmacological research - 1 Sept 1992

Pollis F, Bronte V, Mandruzzato S, Rosato A, Zambon A, Zanovello P, Zambello R, Callegaro L, Collavo D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Membrane
Share to Gangliosides
Share to Killer Cells, Lymphokine-Activated
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to T-Lymphocytes, Cytotoxic

Source

Open in PubMed

Identifiers

PMID: 1409305
DOI: 10.1016/1043-6618(92)90659-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Inhibition of CTL-line lysis after gangliosides treatment.PMID 1409305Read ↗

Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cellsSemantic proximity Read ↗

A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugatesSemantic proximity Read ↗

The leukemic effect of anticholinesterases.Semantic proximity Read ↗

Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthaseSemantic proximity Read ↗

Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.Semantic proximity Read ↗

Characterization of gangliosides from Ehrlich ascites tumour cells and their variants.Semantic proximity Read ↗

Tumor suppressive functions of ceramide: evidence and mechanismsSemantic proximity Read ↗

The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.